Phase 3, Double-Blind, Placebo-Controlled Study of MEDI4736 After Chemoradiation in Stage III, Locally Advanced, Unresectable NSCLC (PACIFIC)

被引：0

作者：

Cho, Byoung Chul ^{[1
]}

Kim, Joo-Hang ^{[1
]}

Villegas, Augusto ^{[2
]}

Frusch, Nicolas ^{[3
]}

Murakami, Shuji ^{[4
]}

Shi, Kelvin ^{[5
]}

Ibrahim, Ramy ^{[5
]}

Ballas, Marc ^{[5
]}

Antonia, Scott J. ^{[6
]}

机构：

[1] Yonsei Univ Hlth Syst, Severance Hosp, Yonsei Canc Ctr, Seoul, South Korea

[2] Canc Specialists North Florida, Jacksonville, FL USA

[3] Ctr Hosp Ardenne, Libramont, Belgium

[4] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan

[5] Astrazeneca, Gaithersburg, MD USA

[6] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期

关键词：

NSCLC; MEDI4736; PD-L1; Immunotherapy;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P3.01-090

引用

页码：S668 / S668

页数：1

共 50 条

[21] Phase 2 Study of MEDI4736 in Patients with PD-L1+Locally Advanced or Metastatic Stage IIIb-IV NSCLC Treated with ≥ 2 Prior Regimens (ATLANTIC)
Garassino, Marina C.
Barlesi, Fabrice
Chaff, Jamie
Shi, Kelvin
Ibrahim, Ramy
Stockman, Paul
Ballas, Marc
Rizvi, Naiyer A.
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S429 - S429
[22] A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Tenecteplase for Improvement of Hemodialysis Catheter Function: TROPICS 3
Tumlin, James
Goldman, Jesse
Spiegel, David M.
Roer, David
Ntoso, K. Adu
Blaney, Martha
Jacobs, Joan
Gillespie, Barbara S.
Begelman, Susan M.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04): : 631 - 636
[23] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
Kopecky, E.
O'Connor, M.
Varanasi, R.
Saim, S.
Fleming, A.
JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
[24] APREMILAST FOR BEHCET'S SYNDROME: A PHASE III RANDOMISED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY (RELIEF)
Hatemi, G.
Mahr, A.
Takeno, M.
Kim, D. -Y.
Melikoglu, M.
Cheng, S.
McCue, S.
Paris, M.
Wang, Y.
Yazici, Y.
ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 91 - 91
[25] A Phase 3, Double-blind, Placebo-Controlled Trial of Idebenone in Friedreich Ataxia
Lynch, David R.
Perlman, Susan L.
Meier, Thomas
ARCHIVES OF NEUROLOGY, 2010, 67 (08) : 941 - 947
[26] REGENERATE: A Global Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of OCA for NASH
Ratziu, Vlad
Sanyal, Arun J.
MacConell, Leigh
Herrmann, Sibylle
Shringarpure, Reshma
Marmon, Tonya
Shapiro, David
Younossi, Zobair M.
SWISS MEDICAL WEEKLY, 2016, 146 : 17S - 17S
[27] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Hu, Bo
Li, Gang
Li, Xiaohong
Wu, Shan
Yu, Tingmin
Li, Xiang
Zhao, Hongru
Jia, Zhihua
Zhuang, Junpeng
Yu, Shengyuan
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
[28] ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Tarantino, M.
Bussel, J.
Blanchette, V.
Despotovic, J.
Bennett, C.
Raj, A.
Williams, B.
Beam, D.
Morales, J.
Rose, M.
Carpenter, N.
Eisen, M.
HAEMATOLOGICA, 2016, 101 : 137 - 137
[29] Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
Bo Hu
Gang Li
Xiaohong Li
Shan Wu
Tingmin Yu
Xiang Li
Hongru Zhao
Zhihua Jia
Junpeng Zhuang
Shengyuan Yu
The Journal of Headache and Pain, 2022, 23
[30] Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study
Tarantino, Michael D.
Bussel, James B.
Blanchette, Victor S.
Despotovic, Jenny
Bennett, Carolyn
Raj, Ashok
Williams, Bronwyn
Beam, Donald
Morales, Jaime
Rose, Melissa J.
Carpenter, Nancy
Nie, Kun
Eisen, Melissa
LANCET, 2016, 388 (10039): : 45 - 54

← 1 2 3 4 5 →